SCD and Parkinson disease: MUFA are synthesized by the enzyme SCD, and multiple lines of evidence indicate that inhibition of SCD reduces α‐synuclein toxicity in PD models, and thus SCD inhibitors have been trialed in PD patients.8, 9, 10, 11